Inhibitor Therapeutics (INTI) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free INTI Stock Alerts $0.09 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Inhibitor Therapeutics Short Interest DataCurrent Short Volume2,300 sharesPrevious Short Volume500 sharesChange Vs. Previous Month+360.00%Dollar Volume Sold Short$178.25Short Interest Ratio / Days to Cover0.5Last Record DateApril 15, 2024Outstanding Shares171,968,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume0 sharesAverage Trading Volume6,543 sharesToday's Volume Vs. Average0% Short Selling Inhibitor Therapeutics ? Sign up to receive the latest short interest report for Inhibitor Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatINTI Short Interest Over TimeINTI Days to Cover Over TimeINTI Percentage of Float Shorted Over Time Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << Inhibitor Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,300 shares $178.25 +360.0%N/A0.5 $0.08 3/31/2024500 shares $35.00 +400.0%N/A0 $0.07 3/15/2024100 shares $7.70 -99.6%N/A0 $0.08 2/29/202424,800 shares $1,984.00 No ChangeN/A0.5 $0.08 11/30/2023100 shares $9.05 -94.1%N/A0 $0.09 11/15/20231,700 shares $204.00 +1,600.0%N/A0.1 $0.12 Get the Latest News and Ratings for INTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibitor Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2023100 shares $5.15 -98.2%N/A0 $0.05 10/15/20235,600 shares $268.80 No ChangeN/A1 $0.05 9/30/20235,600 shares $302.40 -73.1%N/A0.4 $0.05 9/15/202320,800 shares $1,123.20 No ChangeN/A0.3 $0.05 8/15/20232,400 shares $49.92 No ChangeN/A0 $0.02 5/31/20231,500 shares $48.00 -25.0%N/A0.2 $0.03 5/15/20232,000 shares $78.00 No ChangeN/A0.1 $0.04 11/15/20223,300 shares $198.00 +37.5%N/A0.1 $0.06 10/31/20222,400 shares $117.12 No ChangeN/A3 $0.05 10/15/20222,400 shares $105.48 No ChangeN/A4.8 $0.04 9/30/20222,400 shares $123.60 +118.2%N/A0.2 $0.05 9/15/20221,100 shares $97.68 No ChangeN/A0 $0.09 8/31/20221,100 shares $97.68 No ChangeN/A0 $0.09 4/30/2022100 shares $14.38 No ChangeN/A0.3 $0.14 4/15/2022100 shares $14.39 -50.0%N/A0 $0.14 3/31/2022200 shares $26.10 No ChangeN/A0.3 $0.13 3/15/2022200 shares $31.56 No ChangeN/A2 $0.16 2/28/2022200 shares $31.56 No ChangeN/A0.7 $0.16 2/15/2022200 shares $26.07 No ChangeN/A0.1 $0.13 1/31/2022200 shares $26.11 No ChangeN/A0.1 $0.13 11/15/20212,000 shares $318.60 No ChangeN/A0.1 $0.16 10/15/20213,000 shares $480.00 No ChangeN/A0.1 $0.16 9/30/20213,000 shares $450.90 +500.0%N/A0.3 $0.15 9/15/2021500 shares $61.05 -16.7%N/A0.5 $0.12 8/31/2021600 shares $79.80 No ChangeN/A0 $0.13 8/13/2021600 shares $120.18 No ChangeN/A0 $0.20 7/30/2021600 shares $144.00 -79.3%N/A0.1 $0.24 7/15/20212,900 shares $697.45 +26.1%N/A0.8 $0.24 6/30/20212,300 shares $553.38 +2,200.0%N/A0 $0.24 6/15/2021100 shares $12.00 -88.9%N/A0 $0.12 5/28/2021900 shares $71.01 -10.0%N/A0.1 $0.08 5/14/20211,000 shares $75.20 +900.0%N/A0.1 $0.08 4/30/2021100 shares $6.50 -98.4%N/A0 $0.07 4/15/20216,300 shares $472.50 +65.8%N/A0.8 $0.08World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. INTI Short Interest - Frequently Asked Questions What is Inhibitor Therapeutics' current short interest? Short interest is the volume of Inhibitor Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,300 shares of INTI short. Learn More on Inhibitor Therapeutics' current short interest. Is Inhibitor Therapeutics' short interest increasing or decreasing? Inhibitor Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 2,300 shares, an increase of 360.0% from the previous total of 500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Inhibitor Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Inhibitor Therapeutics: Clever Leaves Holdings Inc. (0.61%), Lixte Biotechnology Holdings, Inc. (4.59%), ASLAN Pharmaceuticals Limited (1.47%), Pulmatrix, Inc. (0.32%), BetterLife Pharma Inc. (0.01%), Pasithea Therapeutics Corp. (1.34%), Medicure Inc. (0.06%), TFF Pharmaceuticals, Inc. (2.77%), Theriva Biologics, Inc. (2.35%), eFFECTOR Therapeutics, Inc. (7.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Inhibitor Therapeutics stock? Short selling INTI is an investing strategy that aims to generate trading profit from Inhibitor Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Inhibitor Therapeutics? A short squeeze for Inhibitor Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INTI, which in turn drives the price of the stock up even further. How often is Inhibitor Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INTI, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CLVR Short Interest LIXT Short Interest ASLN Short Interest PULM Short Interest BETRF Short Interest KTTA Short Interest MCUJF Short Interest TFFP Short Interest TOVX Short Interest EFTR Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:INTI) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the Markets